Early cancer screening can play a transformative role in healthcare, potentially saving lives by identifying cancer before it progresses to an advanced, less treatable stage. However, designing ...
The guidelines, published Jan. 5 by the Health Resources and Services Administration, now recommend that average-risk women ...
In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...
Guardant Health aims to reshape how the U.S. gets screened for colorectal cancer, by claiming a groundbreaking FDA approval for a tumor-detecting blood test aimed at a population of about 120 million ...
In May 2024, the Food and Drug Administration (FDA) approved two new cervical screening tests for detecting human papillomavirus (HPV), which causes almost all cervical cancers. Both allow individuals ...
Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...
The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...
The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback